Pharmabiz3d
Takeda’s flagship GICC to create 750 jobs, foster technological innovation with emphasis on plasma-based therapy
Takeda, a global leader in biopharmaceutical innovation, has inaugurated its flagship Global Innovation Capability Centre (ICC). The Takeda India ICC is a part of Takeda’s Data, Digital & Technology ...
Pharmabiz3d
Chugai Pharma to transfer future marketing of anti-cancer agent, Tarceva tablets 25, 100 & 150 in Japan to Cheplapharm
Chugai Pharmaceutical Co., Ltd. and Cheplapharm K.K. announced that Chugai will transfer the business in Japan concerning the anti-cancer agent Tarceva tablets 25, 100, and 150 to Cheplapharm. Chugai ...
Pharmabiz3d
NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2
New findings from the National Institutes of Health’s (NIH) Researching Covid to Enhance Recovery (RECOVER) Initiative suggest that infection with SARS-CoV-2, the virus that causes Covid-19, may be ...
Pharmabiz3d
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company, announces that the Scottish Medicines Consortium (SMC) has published recommendations that Agamree (vamorolone) is accepted for use ...
Pharmabiz3d
THE JAN VISHWAS ACT
The Indian Parliament had passed the Jan Vishwas (Amendment of Provisions) Bill, 2023 to remove stringent punishments such as imprisonment from some of the provisions of the Drugs and Cosmetics Act, ...
Pharmabiz3d
REGENXBIO & Nippon Shinyaku enter exclusive partnership to develop and commercialize RGX-121 and RGX-111 for MPS diseases
REGENXBIO Inc., a leading clinical-stage biotechnology company, and Nippon Shinyaku Co., Ltd. (Nippon Shinyaku) announced a strategic partnership for the development and commercialization of RGX-121 ...
Pharmabiz5d
KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes
The Karnataka Pharma Retailers and Distributors Organization (KPRDO) has now asked the newly formed Karnataka Food and Drug Administration (FDA) to immediately look into the issue of dangerous drug ...
Pharmabiz3d
DGFT notifies updated export policy aligned with Finance Act 2024 to boost pharma trade efficiency
In a major step to align India’s pharma export regulations with global standards, the Directorate General of Foreign Trade (DGFT) has officially notified the updated Schedule-II (Export Policy) of ITC ...
Pharmabiz11h
UCB’s 320 mg/2 mL prefilled syringe and autoinjector for single-injection administration option is available now in US
UCB’s 320 mg/2 mL prefilled syringe and autoinjector for single-injection administration option is available now in US: Brussels, Belgium Saturday, January 18, 2025, 16:00 Hrs [ ...
Pharmabiz3d
BioArctic announces US FDA accepts Eisai’s BLA for subcutaneous maintenance dosing of Leqembi
BioArctic AB (publ) announced that the US Food and Drug Administration (FDA) has accepted BioArctic’s partner Eisai’s Biologics License Application (BLA) for Leqembi subcutaneous autoinjector (SC-AI) ...
Pharmabiz3d
United We Care introduces United-MedASR, a most accurate medical automatic speech recognition
Deep tech startup United We Care (UWC) announced the launch of United-MedASR, an advanced Medical Automatic Speech Recognition (ASR) model, which sets new global benchmarks for clinical accuracy. The ...
Pharmabiz3d
Regeneron announces adjuvant Libtayo significantly improves DFS after surgery in high-risk CSCC in phase 3 trial
Regeneron Pharmaceuticals, Inc. announced positive results from the phase 3 C-POST trial, which demonstrated that adjuvant treatment with PD-1 inhibitor Libtayo (cemiplimab) led to a statistically ...